pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Coadministration of CYP3A4 inducers could lower sufentanil stages and efficacy, probably precipitating withdrawal syndrome in patients that have made Actual physical dependence to sufentanil. Discontinuation of co